BSEBoard Meeting10 Aug 2026 · 10 Aug 2026, 07:25 pm

Godavari Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve the Un-audited Financial Results ....

Godavari Drugs Ltd · 530317

✦ AI SummaryResults

Godavari Drugs Ltd has scheduled a Board Meeting on August 14, 2026, to consider and approve the Un-audited Financial Results for the quarter ended June 30, 2026, along with a Limited review report.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Godavari Drugs Ltd - 530317 - Board Meeting Intimation for Considering And Approving The Un-Audited Financial Results Of The Company For The Quarter Ended June 30, 2026.

Attachments (1)

📄

ad6ee6b9-947f-4ab6-a1e0-0e0bcb1b40a4.pdf

pdf

Download →
View document text
GODAVARI DRUGS LIMITED Regd. Off.:‘Mayfair’, S.P. Road, Secunderabad - 500 003. TS, India. Voice : +91-40-2784 9700 / 2784 2602 / 2784 4557 E-mail : info@godavaridrugs.com | Website : www.godavaridrugs.com Date: 10.08.2026 The General Manager Listing, The Corporate Relations Department, BSE LIMITED PJ Towers, 25th floor, Dalal Street, Mumbai -400 001. Scrip Code: 530317 Dear Sir,/Madam Sub: Intimation of the Board Meeting of Godavari Drugs Limited (the ‘Company’) to be held on Friday, August 14th, 2026 Pursuant to Regulation 29 (1)(a) of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015 and applicable provisions of the Companies Act, we wish to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Friday, August 24, 2026 inter-alia to consider and approve the following business: 1. Un-Audited Financial Results for the 01st quarter ended 30th June, 2026 along with Limited review report (“Financial Results”). 2. Any other business with the permission of Chair. Further as intimated vide our letter dated 23rd June, 2026 and pursuant to the Company's Code of Conduct for Regulating, Monitoring and Reporting of Trading by Insiders ('the Code'), the trading window for dealing in securities of the Company for persons specified under the code, had been closed from 1st July, 2026 and shall be open 48 hours after declaration of Un-Audited Financial Results of the Company for the quarter ended 30th June, 2026. You are kindly requested to take above information on record. Thank you for your attention. Thanking You Yours Sincerely For Godavari Drugs Limited VENKATESH ACHANTA Company Secretary & Compliance Officer Plant : A-6/2, MIDC, Nanded - 431 603. MS, India. E-mail : nnd@godavaridrugs.comCIN:L24230TG1987PLC008016